Lexogen and Bluebee collaborate to streamline QuantSeq-UMI Sequencing Data Analysis Pipeline

Vienna, Austria and Rijswijk, The Netherlands: 12 June 2018 - Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the Bluebee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs the opportunity to analyze samples in a convenient and rapid manner without the need for prior bioinformatics experience.

More info on Bluebee's website.


Next > Bluebee achieves ISO 13485 Medical Device Quality Standard Certification

Previous > Sensolus launches next generation tracking devices in cooperation with Jorjin Technologies Inc and STMicroelectronics